Works matching IS 21986576 AND DT 2022 AND VI 9 AND IP 4
Results: 27
A Randomized Pharmacokinetic Study in Healthy Male Subjects Comparing a High-concentration, Citrate-free SB5 Formulation (40 mg/0.4 ml) and Prior SB5 (Adalimumab Biosimilar).
- Published in:
- Rheumatology & Therapy, 2022, v. 9, n. 4, p. 1157, doi. 10.1007/s40744-022-00471-8
- By:
- Publication type:
- Article
Publisher Correction to: Collagen Turnover Biomarkers Associate with Active Psoriatic Arthritis and Decrease with Guselkumab Treatment in a Phase 3 Clinical Trial (DISCOVER-2).
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Plasma Exchange in a Patient with Immune Thrombocytopenia Associated with Antiphospholipid Syndrome Hospitalized for COVID-19.
- Published in:
- 2022
- By:
- Publication type:
- Case Study
Dactylitis and Early Onset Psoriasis in Psoriatic Arthritis: Are they Markers of Disease Severity? A Clinical Study.
- Published in:
- Rheumatology & Therapy, 2022, v. 9, n. 4, p. 1203, doi. 10.1007/s40744-022-00468-3
- By:
- Publication type:
- Article
Efficacy of Abatacept Versus Tumor Necrosis Factor Inhibitors in Anti-citrullinated Protein Antibody-Positive Patients with Rheumatoid Arthritis: Results from a Korean Nationwide Biologics Registry.
- Published in:
- Rheumatology & Therapy, 2022, v. 9, n. 4, p. 1143, doi. 10.1007/s40744-022-00467-4
- By:
- Publication type:
- Article
Health Economic Evaluation of a High and Low Molecular Weight Hyaluronic Acid Formulation for the Treatment of Knee Osteoarthritis. Post Hoc Analyses from a Randomized Clinical Trial.
- Published in:
- Rheumatology & Therapy, 2022, v. 9, n. 4, p. 1119, doi. 10.1007/s40744-022-00466-5
- By:
- Publication type:
- Article
The Non-medical Switch from Reference Adalimumab to Biosimilar Adalimumab is Highly Successful in a Large Cohort of Patients with Stable Inflammatory Rheumatic Joint Diseases: A Real-Life Observational Study.
- Published in:
- Rheumatology & Therapy, 2022, v. 9, n. 4, p. 1109, doi. 10.1007/s40744-022-00465-6
- By:
- Publication type:
- Article
Association between TNFi anti-drug antibodies, smoking, and disease activity in patients with inflammatory arthritis: Results from a Norwegian cross-sectional observational study.
- Published in:
- Rheumatology & Therapy, 2022, v. 9, n. 4, p. 1171, doi. 10.1007/s40744-022-00464-7
- By:
- Publication type:
- Article
Correction to: Real-world Treatment Patterns and Clinical Outcomes of Baricitinib in Rheumatoid Arthritis patients in Spain: Results of a multicenter, observational study in routine clinical practice (The ORBIT-RA Study).
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
COVID-19 Outcomes and Vaccination in Patients with Spondyloarthritis.
- Published in:
- Rheumatology & Therapy, 2022, v. 9, n. 4, p. 993, doi. 10.1007/s40744-022-00462-9
- By:
- Publication type:
- Article
Clinical Characteristics of Potential "Difficult-to-treat" Patients with Psoriatic Arthritis: A Retrospective Analysis of a Longitudinal Cohort.
- Published in:
- Rheumatology & Therapy, 2022, v. 9, n. 4, p. 1193, doi. 10.1007/s40744-022-00461-w
- By:
- Publication type:
- Article
Interim 2-Year Analysis from SERENA: A Real-World Study in Patients with Psoriatic Arthritis or Ankylosing Spondylitis Treated with Secukinumab.
- Published in:
- Rheumatology & Therapy, 2022, v. 9, n. 4, p. 1129, doi. 10.1007/s40744-022-00460-x
- By:
- Publication type:
- Article
Letter to the Editor Regarding Esophageal Dysfunction and Systemic Sclerosis: Drugs Should be Kept in Mind.
- Published in:
- Rheumatology & Therapy, 2022, v. 9, n. 4, p. 1237, doi. 10.1007/s40744-022-00459-4
- By:
- Publication type:
- Article
A Response to: Letter to the Editor Regarding [Esophageal Dysfunction and Systemic Sclerosis: Drugs Should be Kept in Mind].
- Published in:
- Rheumatology & Therapy, 2022, v. 9, n. 4, p. 1241, doi. 10.1007/s40744-022-00458-5
- By:
- Publication type:
- Article
A Response to: Letter to the Editor Regarding the Article: "Colchicine Against SARS-CoV-2 Infection: What is the Evidence?".
- Published in:
- Rheumatology & Therapy, 2022, v. 9, n. 4, p. 1233, doi. 10.1007/s40744-022-00457-6
- By:
- Publication type:
- Article
Letter to the Editor Regarding "Colchicine Against SARS-CoV-2 Infection: What is the Evidence?".
- Published in:
- Rheumatology & Therapy, 2022, v. 9, n. 4, p. 1229, doi. 10.1007/s40744-022-00456-7
- By:
- Publication type:
- Article
Exploring the Association Between History of Psoriasis (PSO) and Disease Activity in Patients with Psoriatic Arthritis (PsA).
- Published in:
- Rheumatology & Therapy, 2022, v. 9, n. 4, p. 1079, doi. 10.1007/s40744-022-00455-8
- By:
- Publication type:
- Article
Real-World Effectiveness of Belimumab in Systemic Lupus Erythematosus: A Systematic Literature Review.
- Published in:
- Rheumatology & Therapy, 2022, v. 9, n. 4, p. 975, doi. 10.1007/s40744-022-00454-9
- By:
- Publication type:
- Article
Diabetes-Related Complications and Costs in Medicare Beneficiaries with Comorbid Rheumatoid Arthritis and Diabetes Treated with Abatacept Versus Other Targeted DMARDs.
- Published in:
- Rheumatology & Therapy, 2022, v. 9, n. 4, p. 1091, doi. 10.1007/s40744-022-00453-w
- By:
- Publication type:
- Article
Abnormalities of Peripheral Lymphocyte Subsets in Rheumatoid Arthritis Patients Complicated with Osteoporosis.
- Published in:
- Rheumatology & Therapy, 2022, v. 9, n. 4, p. 1049, doi. 10.1007/s40744-022-00452-x
- By:
- Publication type:
- Article
A Response to: Letter to the Editor Regarding Ultrasound Features of Adhesive Capsulitis.
- Published in:
- Rheumatology & Therapy, 2022, v. 9, n. 4, p. 1225, doi. 10.1007/s40744-022-00451-y
- By:
- Publication type:
- Article
A Review of the Clinical Effectiveness and Safety of Hybrid Cooperative Complexes in Intra-articular Viscosupplementation.
- Published in:
- Rheumatology & Therapy, 2022, v. 9, n. 4, p. 957, doi. 10.1007/s40744-022-00450-z
- By:
- Publication type:
- Article
Disease Control with Upadacitinib in Patients with Psoriatic Arthritis: A Post Hoc Analysis of the Randomized, Placebo-Controlled SELECT-PsA 1 and 2 Phase 3 Trials.
- Published in:
- Rheumatology & Therapy, 2022, v. 9, n. 4, p. 1181, doi. 10.1007/s40744-022-00449-6
- By:
- Publication type:
- Article
Associations of Healthcare Utilization and Costs with Increasing Pain and Treatment Intensity Levels in Osteoarthritis Patients: An 18-Year Retrospective Study.
- Published in:
- Rheumatology & Therapy, 2022, v. 9, n. 4, p. 1061, doi. 10.1007/s40744-022-00448-7
- By:
- Publication type:
- Article
Letter to the Editor Regarding "Ultrasound Features of Adhesive Capsulitis".
- Published in:
- Rheumatology & Therapy, 2022, v. 9, n. 4, p. 1221, doi. 10.1007/s40744-022-00447-8
- By:
- Publication type:
- Article
Real-World Effectiveness and Treatment Retention of Secukinumab in Patients with Psoriatic Arthritis and Axial Spondyloarthritis: A Descriptive Observational Analysis of the Spanish BIOBADASER Registry.
- Published in:
- Rheumatology & Therapy, 2022, v. 9, n. 4, p. 1031, doi. 10.1007/s40744-022-00446-9
- By:
- Publication type:
- Article
Collagen Turnover Biomarkers Associate with Active Psoriatic Arthritis and Decrease with Guselkumab Treatment in a Phase 3 Clinical Trial (DISCOVER-2).
- Published in:
- Rheumatology & Therapy, 2022, v. 9, n. 4, p. 1017, doi. 10.1007/s40744-022-00444-x
- By:
- Publication type:
- Article